DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS

DORNASE ALFA IN RUSSIA: 15 YEARS LATER. EFFICACY OF THE DRUG IN THE BASIC TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS

The 15-years practice of Pulmozyme (dornase alfa) usage showed its high efficacy and safety in cystic fibrosis treatment in children of various age, including infants. The efficacy of the drug is associate with clinical effects: strong mucolytic, anti-inflammatory and antibacterial effects. The appr...

Full description

Bibliographic Details
Main Authors: O. I. Simonova, O. F. Lukina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2012-03-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
cystic fibrosis
dornase alfa
children
mucostasis
chronic non-specific lung diseases
chronic polypous pansinusitis
cystic
fibrosis basic treatment
Online Access:https://vsp.spr-journal.ru/jour/article/view/133

Internet

https://vsp.spr-journal.ru/jour/article/view/133

Similar Items